127 related articles for article (PubMed ID: 12298117)
21. [Study on the reliability of CardioChek PA for measuring lipid profile].
Gao Y; Zhu CG; Wu NQ; Guo YL; Liu G; Dong Q; Li JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):523-8. PubMed ID: 27318918
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
[TBL] [Abstract][Full Text] [Related]
23. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers.
Whitehead SJ; Ford C; Gama R
Ann Clin Biochem; 2014 Jan; 51(Pt 1):54-67. PubMed ID: 23880620
[TBL] [Abstract][Full Text] [Related]
24. How accurate is the Reflotron cholesterol analyzer? 1. Accuracy of reflotron misrepresented in study.
van Beurden E; James R
Am J Public Health; 1993 Mar; 83(3):428-9. PubMed ID: 8438986
[No Abstract] [Full Text] [Related]
25. Validity of a portable glucose, total cholesterol, and triglycerides multi-analyzer in adults.
Coqueiro Rda S; Santos MC; Neto Jde S; Queiroz BM; Brügger NA; Barbosa AR
Biol Res Nurs; 2014 Jul; 16(3):288-94. PubMed ID: 23871994
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of seven Cholestech L.D.X analyzers for total cholesterol determinations.
Rogers EJ; Misner L; Ockene IS; Nicolosi RJ
Clin Chem; 1993 May; 39(5):860-4. PubMed ID: 8485877
[TBL] [Abstract][Full Text] [Related]
27. Results of a province-wide quality assurance program assessing the accuracy of cholesterol, triglycerides, and high-density lipoprotein cholesterol measurements and calculated low-density lipoprotein cholesterol in Ontario, using fresh human serum.
McQueen MJ; Henderson AR; Patten RL; Krishnan S; Wood DE; Webb S
Arch Pathol Lab Med; 1991 Dec; 115(12):1217-22. PubMed ID: 1768212
[TBL] [Abstract][Full Text] [Related]
28. Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement.
Contois JH; Warnick GR; Sniderman AD
J Clin Lipidol; 2011; 5(4):264-72. PubMed ID: 21784371
[TBL] [Abstract][Full Text] [Related]
29. Measurement of cholesterol, triglycerides, and HDL using compact analysis systems.
Warnick GR
Clin Lab Med; 1989 Mar; 9(1):73-88. PubMed ID: 2647378
[TBL] [Abstract][Full Text] [Related]
30. How reliably can compact chemistry analyzers measure lipids?
Kaufman HW; McNamara JR; Anderson KM; Wilson PW; Schaefer EJ
JAMA; 1990 Mar; 263(9):1245-9. PubMed ID: 2304240
[TBL] [Abstract][Full Text] [Related]
31. Precision and accuracy of a portable blood analyzer system during cholesterol screening.
Greenland P; Bowley NL; French CA; Meiklejohn B; Gagliano S; Sparks CE
Am J Public Health; 1990 Feb; 80(2):181-4. PubMed ID: 2404422
[TBL] [Abstract][Full Text] [Related]
32. Point-of-care testing of cholesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in system.
Rapi S; Bazzini C; Tozzetti C; Sbolci V; Modesti PA
Transl Res; 2009 Feb; 153(2):71-6. PubMed ID: 19138651
[TBL] [Abstract][Full Text] [Related]
33. The concept of precision extended to the atherogenic index of plasma.
Holmes DT; Frohlich J; Buhr KA
Clin Biochem; 2008 May; 41(7-8):631-5. PubMed ID: 18280809
[TBL] [Abstract][Full Text] [Related]
34. Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins.
Perera NJ; Burns JC; Perera RS; Lewis B; Sullivan DR
J Clin Lipidol; 2010; 4(4):305-9. PubMed ID: 21122664
[TBL] [Abstract][Full Text] [Related]
35. [Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay].
Egloff M; Léglise D; Duvillard L; Steinmetz J; Boyer MJ; Ruelland A; Agher R; Beucler I
Ann Biol Clin (Paris); 1999; 57(5):561-72. PubMed ID: 10518058
[TBL] [Abstract][Full Text] [Related]
36. How accurate is the Reflotron cholesterol analyzer? 2. Reflotron screenings considered a success.
Feil JM
Am J Public Health; 1993 Mar; 83(3):428-9. PubMed ID: 8438987
[No Abstract] [Full Text] [Related]
37. Evaluation of the Dade Behring Dimension RxL clinical chemistry analyzer.
Cuka S; Dvornik S; Drazenović K; Mihić J
Clin Lab; 2001; 47(1-2):35-40. PubMed ID: 11214221
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two point of care devices for capillary lipid screening in fasting and postprandial adults.
Donato LJ; Deobald GR; Wockenfus AM; Hornseth JM; Saenger AK; Karon BS
Clin Biochem; 2015 Feb; 48(3):174-6. PubMed ID: 25448034
[TBL] [Abstract][Full Text] [Related]
39. Laboratory measurement of lipid and lipoprotein risk factors.
Warnick GR
Scand J Clin Lab Invest Suppl; 1990; 198():9-19. PubMed ID: 2189213
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the ratio HDL-cholesterol/total cholesterol on the Reflotron vs. conventional wet chemistry methods.
Herruer MH; Kluitenberg WE; Zuijderhoudt FM
Eur J Clin Chem Clin Biochem; 1992 Mar; 30(3):153-5. PubMed ID: 1599979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
